Park H - Search Results

1

Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.

Park H, Otani H, Noda T, Sato D, Okazaki T, Ueyama T, Iwasaka J, Yamamoto Y, Iwasaka T. Park H, et al. Int J Cardiol. 2013 Aug 20;167(4):1547-51. doi: 10.1016/j.ijcard.2012.04.096. Epub 2012 May 18. Int J Cardiol. 2013. PMID: 22608892 Clinical Trial.

2

Efficacy of intracoronary administration of a short-acting β-blocker landiolol during reperfusion in pigs.

Park H, Otani H, Oishi C, Fujikawa M, Yamashita K, Okazaki T, Sato D, Ueyama T, Iwasaka J, Yamamoto Y, Iwasaka T. Park H, et al. Int J Cardiol. 2011 Feb 3;146(3):347-53. doi: 10.1016/j.ijcard.2009.07.013. Epub 2009 Aug 25. Int J Cardiol. 2011. PMID: 19709770

3

Three-dimensional echocardiographic assessment of left ventricular function in takotsubo cardiomyopathy.

Fujikawa M, Iwasaka J, Oishi C, Ueyama T, Park H, Yamamoto Y, Otani H, Iwasaka T. Fujikawa M, et al. Among authors: park h. Heart Vessels. 2008 May;23(3):214-6. doi: 10.1007/s00380-007-1033-6. Epub 2008 May 17. Heart Vessels. 2008. PMID: 18484167

4

Percutaneous coronary intervention for left main trunk ostial stenosis in a patient with Takayasu's arteritis.

Park H, Otani H, Yamamoto Y, Horitani K, Oishi C, Sato D, Ueyama T, Iwasaka J, Iwasaka T. Park H, et al. Cardiovasc Interv Ther. 2011 Jan;26(1):70-3. doi: 10.1007/s12928-010-0026-z. Epub 2010 Jul 3. Cardiovasc Interv Ther. 2011. PMID: 24122503

5

Retrograde fast pathway ablation with the EnSite NavX mapping system for slow-fast atrioventricular node reentrant tachycardia and a prolonged PR interval during sinus rhythm.

Sato D, Otani H, Noda T, Ueyama T, Iwasaka J, Park H, Yamamoto Y, Minato N, Iwasaka T. Sato D, et al. Among authors: park h. J Cardiol Cases. 2011 Apr 12;3(3):e143-e148. doi: 10.1016/j.jccase.2011.03.005. eCollection 2011 Jun. J Cardiol Cases. 2011. PMID: 30532855 Free PMC article.

6

The case of successful catheter ablation using only the approach from the upper part of the subject's body, with meandering aorta and implanted IVC filter.

Sato D, Otani H, Higashiyama S, Masanori F, Iwasaka J, Park H, Yamamoto Y, Minato N, Iwasaka T. Sato D, et al. Among authors: park h. J Cardiol Cases. 2011 Aug 19;4(2):e115-e120. doi: 10.1016/j.jccase.2011.07.001. eCollection 2011 Oct. J Cardiol Cases. 2011. PMID: 30532877 Free PMC article.

7

Comparison of neointimal morphology of in-stent restenosis with sirolimus-eluting stents versus bare metal stents: virtual histology-intravascular ultrasound analysis.

Yamamoto Y, Otani H, Iwasaka J, Park H, Sakuma T, Kamihata H, Iwasaka T. Yamamoto Y, et al. Among authors: park h. Cardiovasc Interv Ther. 2011 Sep;26(3):186-92. doi: 10.1007/s12928-011-0051-6. Epub 2011 Apr 9. Cardiovasc Interv Ther. 2011. PMID: 24122584

8

The incidence, natural history, and predictive factors for tissue protrusion after drug-eluting stent implantation.

Otagaki M, Fujii K, Matsumura K, Noda T, Shibutani H, Hashimoto K, Morishita S, Tsujimoto S, Yamamoto Y, Park H, Yoshioka K, Shiojima I. Otagaki M, et al. Among authors: park h. Catheter Cardiovasc Interv. 2021 Jul 1;98(1):E62-E68. doi: 10.1002/ccd.29551. Epub 2021 Feb 17. Catheter Cardiovasc Interv. 2021. PMID: 33595185

9

Heparin Induces the Mobilization of Heart-Derived Multipotent Mesoangioblasts During Cardiac Surgery With Cardiopulmonary Bypass or Cardiac Catheterization.

Hata Y, Iwasaki M, Fujitaka K, Park H, Sato D, Enoki C, Minato N, Horitani K, Nakano M, Kishimoto H, Wada K, Koyanagi M, Adachi Y, Yamamoto Y, Zeiher AM, Dimmeler S, Shiojima I. Hata Y, et al. Among authors: park h. Circ J. 2018 Apr 25;82(5):1459-1465. doi: 10.1253/circj.CJ-17-0324. Epub 2017 Sep 21. Circ J. 2018. PMID: 28931787 Free article.

10

Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients.

Otagaki M, Matsumura K, Kin H, Fujii K, Shibutani H, Matsumoto H, Takahashi H, Park H, Yamamoto Y, Sugiura T, Shiojima I. Otagaki M, et al. Among authors: park h. Cardiovasc Drugs Ther. 2019 Aug;33(4):435-442. doi: 10.1007/s10557-019-06892-y. Cardiovasc Drugs Ther. 2019. PMID: 31321581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33,697 results

Search Page

Filters